Skip to content
Screener

Johnson & Johnson JNJ Total Revenue

Total Revenue at other companies

Abbott logo
AbbottABT
$12.59B+13.0%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$12.97B+5.7%
Tenet Healthcare logo
Tenet HealthcareTHC
$5.63B+6.8%
Pfizer logo
PfizerPFE
$15.03B+2.6%
Procter & Gamble logo
Procter & GamblePG
$21.2B+1.5%
Merck & Co. logo
Merck & Co.MRK
$16.61B+5.1%

Segments

By product

See full
ELECTROPHYSIOLOGY$5.63B+7.0%
DARZALEX$4.21B+18.9%
SPINE,SPORTS & OTHER$2.85B-2.5%
Other$2.8B-1.8%
Tremfya$2.05B+72.5%
GENERAL$1.46B+5.2%

By geography

See full
Europe$5.73B+6.3%
Asia-Pacific, Africa$3.74B+3.8%
Western Hemisphere, excluding U.S.$1.31B+8.5%

By segment

See full
Innovative Medicine$16.38B+7.8%
MEDTECH$8.93B+4.5%

Other financials

Income statement

See full
Gross profit$17.3B+7.1%
Operating income$7.1B+7.4%
Net income$5.5B-0.1%
EPS (diluted)$2.27-0.9%

Balance sheet

See full
Cash & equivalents$20.4B+9.9%
Total debt$49.0B-3.4%
Total equity$85.0B+8.3%
Total assets$201.06B+4.0%

Cash flow

See full
Operating cash flow$8.6B+122%
CapEx$1.3B+26.7%
Free cash flow$7.3B+157%

Valuation

See full
Market cap$650.67B+52.8%
Enterprise value$679.29B+48.3%
P/E30.9×+12.1×
P/S6.6×+1.9×

Profitability

See full
Gross margin67.9%0.0pp
Operating margin26.5%+2.8pp
Net margin21.5%-3.5pp
FCF margin22.7%+2.2pp

Returns & leverage

See full
Return on equity25.7%-4.5pp
Debt / equity0.6×-0.1×
Current ratio1.1×+0.1×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Johnson & Johnson’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000200406-26-000153
Line itemFiscal Second Quarter Ended / June 28,2026Fiscal Second Quarter Ended / Percentto SalesFiscal Second Quarter Ended / June 29,2025Fiscal Second Quarter Ended / Percentto Sales
Sales to customers (Note 9)$25,310100.0%$23,743100.0%
Cost of products sold8,05131.87,62832.1
Gross profit17,25968.216,11567.9
Selling, marketing and administrative expenses6,43225.45,88924.8
Research and development expense3,65314.43,51614.8
Interest income(219)(0.9)(260)(1.1)
Interest expense, net of portion capitalized2811.13081.3
Other (income) expense, net3311.31070.5

Item 1 — Financial statements

FAQ

What is Johnson & Johnson's total revenue?
Johnson & Johnson (JNJ) reported total revenue of $25.31B in Q2 2026.
How has Johnson & Johnson's total revenue changed year-over-year?
Johnson & Johnson's total revenue increased by 6.6% year-over-year, from $23.74B to $25.31B.
What is the long-term trend for Johnson & Johnson's total revenue?
Over 4 years (2021 to 2025), Johnson & Johnson's total revenue has grown at a 4.6% compound annual growth rate (CAGR), from $78.74B to $94.19B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Johnson & Johnson's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude